Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Colorectal Neoplasms × folfirinox × Clear all

Phase

Status

Completed 3 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 8 Rectal Neoplasms 2 Carcinoma, Hepatocellular 2 Urachal cancer 1 Pancreatic Adenocarcinoma 1 Neoplasms 1 Colorectal Neoplasms 1 Borderline Resectable Pancreatic Cancer 1

Interventions

Fluorouracil 68 Oxaliplatin 62 Leucovorin 53 Irinotecan 53 Capecitabine 51 Bevacizumab 51 Cetuximab 41 Folfox protocol 20 Drug Therapy 20 Neoadjuvant Therapy 18 HMPL-013 15 regorafenib 13 Colonoscopy 13 apatinib 11 XELOX 10 Chemotherapy, Adjuvant 10 raltitrexed 9 Radiotherapy 9 trifluridine tipiracil drug combination 8 sintilimab 8 Surveys and Questionnaires 8 Surgical Procedures, Operative 8 Panitumumab 8 IFL protocol 8 Blood Specimen Collection 8 tislelizumab 7 Laparoscopy 7 Endoscopic Mucosal Resection 7 Aspirin 7 Trastuzumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05081687 2023-10-11

BRAZIL-TNT

Hospital Israelita Albert Einstein

Phase 3 Unknown

Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡